Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98

PHASE3CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2009

Conditions
Breast CancerCognitive/Functional EffectsFatiguePsychosocial Effects of Cancer and Its Treatment
Interventions
PROCEDURE

cognitive assessment

Cognitive function will be assessed using the CogState battery and the Cognitive Failures Questionnaire.

PROCEDURE

fatigue assessment and management

Fatigue will be evaluated using the Brief Fatigue Inventory.

PROCEDURE

psychologic distress

Psychologic distress will be evaluated using the General Health Questionnaire after cognitive testing.

PROCEDURE

quality-of-life assessment

Quality of life will be assessed using global linear analogue self-assessment (LASA) indicators for physical well-being, mood, coping effort (PACIS), perceived social support and subjective health estimation.

Trial Locations (12)

1

Auckland City Hospital, Auckland

1000

Institut Jules Bordet, Brussels

2031

Institute of Oncology at Prince of Wales Hospital, Randwick

3002

Peter MacCallum Cancer Centre, East Melbourne

3065

St. Vincent's Hospital - Melbourne, Fitzroy

3144

Cabrini Hospital, Malvern

20141

European Institute of Oncology, Milan

CH-4031

Universitaetsspital-Basel, Basel

CH-6500

Oncology Institute of Southern Switzerland, Bellinzona

CH-3008

International Breast Cancer Study Group, Bern

CH-9007

Kantonsspital - St. Gallen, Sankt Gallen

DD1 9SY

Ninewells Hospital, Dundee

All Listed Sponsors
lead

ETOP IBCSG Partners Foundation

NETWORK

NCT00343616 - Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98 | Biotech Hunter | Biotech Hunter